WCPO: After 35 years of surviving HIV and AIDS, Carl Fox is part of a study he believes will find a cure
Fox is part of UC's Trailblazer study
Carl Fox of Northern Kentucky found out he was HIV positive in 1985. After decades of living with the virus and watching the deaths of hundreds of friends, he joined a federally funded study and is allowing WCPO-TV to tell his story.
The TRAILBLAZER study, as it’s called, aims to change the parts of a patient’s white blood cells that HIV latches onto, says Carl Fichtenbaum, MD, professor in the Division of Infectious Diseases at the UC College of Medicine.
Fichtenbaum is a principal investigator on the study and has been Fox’s doctor for years.
“The idea behind this study that we’re doing is to take a person’s cells from their white blood cells that harbor that receptor, take it in the laboratory, remove the receptor through genetic engineering and then infuse those cells back into the person,” he tells WCPO.
“Our hope in the future is that perhaps if we were to do this often enough, and change enough cells in the body, that people who have HIV may be able to control the HIV, even without any medication,” Fichtenbaum says. “And it may be the first steps or ideas to really trying to cure people.”
See the full WCPO study here and read more about the TRAILBLAZER study here.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
The reuse revolution: Your guide to upcycled and sustainable...
November 19, 2024
UC alums Meridith Shook and Jacob Schlater., partners and founders of Object From Nothing fashion brand, are featured in an article in the Los Angeles Times on sustainable fashion.
UC researchers secure seven-figure contract from Department of...
November 19, 2024
Launched in 2017 as one of the first initiatives funded by the University of Cincinnati’s Technology Accelerator for Commercialization, now the UC Venture Lab, Sense Neuro Diagnostics, a MedTech startup, has secured a $2 million contract from the United States Department of Defense, the Cincinnati Business Courier reported.
UC celebrates first-generation college students throughout...
November 19, 2024
Students and administrators speak with WLWT, Channel 5, about first-generation college students at the University of Cincinnati. UC is waiving its application fee for all undergraduate programs throughout November. The move is to encourage more first-gen students to consider higher education.